This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
van der Voort van Zyp NC, van der Holt B, van Klaveren RJ, Pattynama P, Maat A, Nuyttens JJ. Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. Lung Cancer 2010; 69: 296-301. 10.1016/j.lungcan.2009.12.008van der Voort van ZypNCvan der HoltBvan KlaverenRJPattynamaPMaatANuyttensJJ.Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancerLung Cancer20106929630110.1016/j.lungcan.2009.12.008Open DOISearch in Google Scholar
Chang JY, Senan S, Paul MA, Mehran RJ, Louie A V, Groen HJM, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2016; 16: 630-7. 10.1016/S1470-2045(15)70168-3ChangJYSenanSPaulMAMehranRJLouieA VGroenHJMet al.Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsLancet Oncol201616630710.1016/S1470-2045(15)70168-3Open DOISearch in Google Scholar
Videtic GMM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, et al. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Int J Radiat Oncol Biol Phys 2010; 77: 344-9. 10.1016/j.ijrobp.2009.05.004VideticGMMStephansKReddyCGajdosSKolarMClouserEet al.Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local controlInt J Radiat Oncol Biol Phys201077344910.1016/j.ijrobp.2009.05.004Open DOISearch in Google Scholar
Bahig H, Filion E, Vu T, Roberge D, Lambert L, Bouchard M, et al. Excellent cancer outcomes following patient-adapted robotic lung SBRT but a case for caution in idiopathic pulmonary fibrosis. Technol Cancer Res Treat 2015; 14: 667-76. 10.7785/tcrt.2012.500445BahigHFilionEVuTRobergeDLambertLBouchardMet al.Excellent cancer outcomes following patient-adapted robotic lung SBRT but a case for caution in idiopathic pulmonary fibrosisTechnol Cancer Res Treat2015146677610.7785/tcrt.2012.500445Open DOISearch in Google Scholar
Davis JN, Medbery C, Sharma S, Perry D, Pablo J, D’Ambrosio DJ, et al. Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry. J Radiat Oncol 2015; 4: 55-63. 10.1007/s13566-014-0177-0DavisJNMedberyCSharmaSPerryDPabloJD’AmbrosioDJet al.Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient RegistryJ Radiat Oncol20154556310.1007/s13566-014-0177-0Open DOISearch in Google Scholar
Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009; 27: 3290-6. 10.1200/JCO.2008.21.5681BaumannPNymanJHoyerMWennbergBGagliardiGLaxIet al.Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapyJ Clin Oncol2009273290610.1200/JCO.2008.21.5681Open DOISearch in Google Scholar
Nuyttens JJ, van der Voort van Zyp NC, Verhoef C, Maat A, van Klaveren RJ, van der Holt B, et al. Stereotactic body radiation therapy for oligometastases to the lung: a Phase 2 Study. Int J Radiat Oncol Biol Phys 2015; 91: 337-43. 10.1016/j.ijrobp.2014.10.021NuyttensJJvan der Voort van ZypNCVerhoefCMaatAvan KlaverenRJvan der HoltBet al.Stereotactic body radiation therapy for oligometastases to the lung: a Phase 2 StudyInt J Radiat Oncol Biol Phys2015913374310.1016/j.ijrobp.2014.10.021Open DOISearch in Google Scholar
Inoue T, Oh R-J, Shiomi H, Masai N, Miura H. Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events. Strahlenther Onkol 2013; 189: 285-92. 10.1007/s00066-012-0290-1InoueTOhR-JShiomiHMasaiNMiuraH.Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory eventsStrahlenther Onkol20131892859210.1007/s00066-012-0290-1Open DOISearch in Google Scholar
Ernst-Stecken A, Lambrecht U, Mueller R, Sauer R, Grabenbauer G. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: First results of a phase I/II study. Strahlenther Onkol 2006; 182: 696-702. 10.1007/s00066-006-1577-xErnst-SteckenALambrechtUMuellerRSauerRGrabenbauerG.Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: First results of a phase I/II studyStrahlenther Onkol200618269670210.1007/s00066-006-1577-xOpen DOISearch in Google Scholar
De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans CW, Le Péchoux C, Price A, et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 2010; 28: 5301-10. 10.1200/JCO.2010.30.3271De RuysscherDFaivre-FinnCNestleUHurkmansCWLe PéchouxCPriceAet al.European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancerJ Clin Oncol20102853011010.1200/JCO.2010.30.3271Open DOISearch in Google Scholar
Vansteenkiste J, De Ruysscher D, Eberhardt WEE, Lim E, Senan S, Felip E, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi89-98. 10.1093/annonc/mdt241VansteenkisteJDe RuysscherDEberhardtWEELimESenanSFelipEet al.Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis treatment and follow-upAnn Oncol2013246vi899810.1093/annonc/mdt241Open DOISearch in Google Scholar
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007; 2(7 Suppl 3): S94-100. 10.1097/JTO.0b013e318074de34OnishiHShiratoHNagataYHiraokaMFujinoMGomiKet al.Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional studyJ Thorac Oncol200727 Suppl 3S9410010.1097/JTO.0b013e318074de34Open DOISearch in Google Scholar
Hof H, Herfarth KK, Münter M, Hoess A, Motsch J, Wannenmacher M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003; 56: 335-41. 10.1016/S0360-3016(02)04504-2HofHHerfarthKKMünterMHoessAMotschJWannenmacherMet al.Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC)Int J Radiat Oncol Biol Phys2003563354110.1016/S0360-3016(02)04504-2Open DOISearch in Google Scholar
Hof H, Hoess A, Oetzel D, Debus J, Herfarth K. Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol 2007; 183: 673-8. 10.1007/s00066-007-1724-zHofHHoessAOetzelDDebusJHerfarthK.Stereotactic single-dose radiotherapy of lung metastasesStrahlenther Onkol2007183673810.1007/s00066-007-1724-zOpen DOISearch in Google Scholar
Senan S, Lagerwaard F. Stereotactic radiotherapy for stage I lung cancer: current results and new developments. Cancer Radiother 2010; 14: 115-8. 10.1016/j.canrad.2009.11.003SenanSLagerwaardF.Stereotactic radiotherapy for stage I lung cancer: current results and new developmentsCancer Radiother201014115810.1016/j.canrad.2009.11.003Open DOISearch in Google Scholar
Chen Y, Guo W, Lu Y, Zou B. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapy. Radiother Oncol 2008; 88: 351-8. 10.1016/j.radonc.2008.07.013ChenYGuoWLuYZouB.Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapyRadiother Oncol200888351810.1016/j.radonc.2008.07.013Open DOISearch in Google Scholar
Berriochoa C, Videtic GMM, Woody NM, Djemil T, Zhuang T, Stephans KL. Stereotactic body radiotherapy for T3N0 lung cancer with chest wall invasion. Clin Lung Cancer 2016; 17: 595-601. 10.1016/j.cllc.2016.04.007BerriochoaCVideticGMMWoodyNMDjemilTZhuangTStephansKL.Stereotactic body radiotherapy for T3N0 lung cancer with chest wall invasionClin Lung Cancer20161759560110.1016/j.cllc.2016.04.007Open DOISearch in Google Scholar
Jereczek-Fossa BA, Ronchi S, Orecchia R. Is stereotactic body radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective? Rep Pract Oncol Radiother 2015; 20: 472-83. 10.1016/j.rpor.2014.10.004Jereczek-FossaBARonchiSOrecchia R. Is stereotactic body radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?Rep Pract Oncol Radiother2015204728310.1016/j.rpor.2014.10.004Open DOISearch in Google Scholar
Meng M, Wang H, Zaorsky NG, Zhao X, Wu Q, Jiang B, et al. Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer. Oncotarget 2015; 6: 15690-703. 10.18632/oncotarget.3704MengMWangHZaorskyNGZhaoXWuQJiangBet al.Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancerOncotarget201561569070310.18632/oncotarget.3704Open DOISearch in Google Scholar
Gibbs IC. Frameless image-guided intracranial and extracranial radiosurgery using the Cyberknife robotic system. Cancer Radiother 2006; 10: 283-7. 10.1016/j.canrad.2006.05.013GibbsIC.Frameless image-guided intracranial and extracranial radiosurgery using the Cyberknife robotic systemCancer Radiother200610283710.1016/j.canrad.2006.05.013Open DOISearch in Google Scholar
Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer CR. The CyberKnife robotic radiosurgery system in 2010. Technol Cancer Res Treat 2010; 9: 433-52. 10.1177/153303461000900502KilbyWDooleyJRKuduvalliGSayehSMaurerCR.The CyberKnife robotic radiosurgery system in 2010Technol Cancer Res Treat201094335210.1177/153303461000900502Open DOISearch in Google Scholar
Timmerman RD. An overview of hypofractionation and introduction to this issue of Seminars in Radiation Oncology. Semin Radiat Oncol 2008; 18: 215-22. 10.1016/j.semradonc.2008.04.001TimmermanRD.An overview of hypofractionation and introduction to this issue of Seminars in Radiation OncologySemin Radiat Oncol2008182152210.1016/j.semradonc.2008.04.001Open DOISearch in Google Scholar
Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010; 37: 4078-101. 10.1118/1.3438081BenedictSHYeniceKMFollowillDGalvinJMHinsonWKavanaghBet al.Stereotactic body radiation therapy: the report of AAPM Task Group 101Med Phys201037407810110.1118/1.3438081Open DOISearch in Google Scholar
Guckenberger M, Heilman K, Wulf J, Mueller G, Beckmann G, Flentje M. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 2007; 85: 435-42. 10.1016/j.radonc.2007.10.044GuckenbergerMHeilmanKWulfJMuellerGBeckmannGFlentjeM.Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT studyRadiother Oncol2007854354210.1016/j.radonc.2007.10.044Open DOISearch in Google Scholar
Essler M, Wantke J, Mayer B, Scheidhauer K, Bundschuh RA, Haller B, et al. Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy. Strahlenther Onkol 2013; 189: 495-501. 10.1007/s00066-013-0310-9EsslerMWantkeJMayerBScheidhauerKBundschuhRAHallerBet al.Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapyStrahlenther Onkol201318949550110.1007/s00066-013-0310-9Open DOISearch in Google Scholar
Chen VJ, Oermann E, Vahdat S, Rabin J, Suy S, Yu X, et al. CyberKnife with tumor tracking: an effective treatment for high-risk surgical patients with stage I non-small cell lung cancer. Front Oncol 2012; 2: 1-5. 10.3389/fonc.2012.00009ChenVJOermannEVahdatSRabinJSuySYuXet al.CyberKnife with tumor tracking: an effective treatment for high-risk surgical patients with stage I non-small cell lung cancerFront Oncol201221510.3389/fonc.2012.00009Open DOISearch in Google Scholar
van der Voort van Zyp NC, Prévost J-B, Hoogeman MS, Praag J, van der Holt B, Levendag PC, et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome. Radiother Oncol 2009; 91: 296-300. 10.1016/j.radonc.2009.02.011van der Voort van ZypNCPrévostJ-BHoogemanMSPraagJvan der HoltBLevendagPCet al.Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcomeRadiother Oncol20099129630010.1016/j.radonc.2009.02.011Open DOISearch in Google Scholar
Factor OB, Vu CC, Schneider JG, Witten MR, Schubach SL, Gittleman AE, et al. Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experience. Front Oncol 2014; 4: 1-5. 10.3389/fonc.2014.00287FactorOBVuCCSchneiderJGWittenMRSchubachSLGittlemanAEet al.Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experienceFront Oncol201441510.3389/fonc.2014.00287Open DOISearch in Google Scholar
Shen Z-T, Wu X-H, Li B, Zhu X-X. Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer. MedOncol 2015; 32: 1-8. 10.1007/s12032-015-0506-1ShenZ-TWuX-HLiBZhuX-X.Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancerMed Oncol2015321810.1007/s12032-015-0506-1Open DOISearch in Google Scholar
Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson M A, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II Study. Int J Radiat Oncol Biol Phys 2009; 75: 677-82. 10.1016/j.ijrobp.2008.11.042FakirisAJMcGarryRCYiannoutsosCTPapiezLWilliamsMHendersonM Aet al.Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II StudyInt J Radiat Oncol Biol Phys2009756778210.1016/j.ijrobp.2008.11.042Open DOISearch in Google Scholar
Guckenberger M, Wulf J, Mueller G, Krieger T, Baier K, Gabor M, et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys 2009; 74: 47-54. 10.1016/j.ijrobp.2008.06.1939GuckenbergerMWulfJMuellerGKriegerTBaierKGaborMet al.Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculationInt J Radiat Oncol Biol Phys200974475410.1016/j.ijrobp.2008.06.1939Open DOISearch in Google Scholar
Duncker-Rohr V, Nestle U, Momm F, Prokic V, Heinemann F, Mix M, et al. Stereotactic ablative radiotherapy for small lung tumors with a moderate dose: Favorable results and low toxicity. Strahlenther Onkol 2013; 189: 33-40. 10.1007/s00066-012-0224-yDuncker-RohrVNestleUMommFProkicVHeinemannFMixMet al.Stereotactic ablative radiotherapy for small lung tumors with a moderate dose: Favorable results and low toxicityStrahlenther Onkol2013189334010.1007/s00066-012-0224-yOpen DOISearch in Google Scholar
Yamamoto T, Jingu K, Shirata Y, Koto M, Matsushita H, Sugawara T, et al. Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors. BMC Cancer 2014; 14: 464. 10.1186/1471-2407-14-464YamamotoTJinguKShirataYKotoMMatsushitaHSugawaraTet al.Outcomes after stereotactic body radiotherapy for lung tumors with emphasis on comparison of primary lung cancer and metastatic lung tumorsBMC Cancer20141446410.1186/1471-2407-14-464Open DOISearch in Google Scholar
Senthi S, Haasbeek CJ a, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review. Radiother Oncol 2013; 106: 276-82. 10.1016/j.radonc.2013.01.004SenthiSHaasbeekCJaSlotmanBJSenanS.Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic reviewRadiother Oncol20131062768210.1016/j.radonc.2013.01.004Open DOISearch in Google Scholar
Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, et al. Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis. Strahlenther Onkol 2014; 191: 125-32. 10.1007/s00066-014-0739-5SchanneDHNestleUAllgäuerMAndratschkeNAppoldSDieckmannUet al.Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysisStrahlenther Onkol20141911253210.1007/s00066-014-0739-5Open DOISearch in Google Scholar
Brown WT, Wu X, Fayad F, Fowler JF, García S, Monterroso MI, et al. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Clin Oncol 2009; 21: 623-31. 10.1016/j.clon.2009.06.006BrownWTWuXFayadFFowlerJFGarcíaSMonterrosoMIet al.Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intentClin Oncol2009216233110.1016/j.clon.2009.06.006Open DOISearch in Google Scholar
Collins BT, Vahdat S, Erickson K, Collins SP, Suy S, Yu X, et al. Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer. J Hematol Oncol 2009; 2: 1. 10.1186/1756-8722-2-1CollinsBTVahdatSEricksonKCollinsSPSuySYuXet al.Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancerJ Hematol Oncol20092110.1186/1756-8722-2-1Open DOISearch in Google Scholar
Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, et al. CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. J Hematol Oncol 2010; 3: 6. 10.1186/1756-8722-3-6VahdatSOermannEKCollinsSPYuXAbedalthagafiMDebritoPet al.CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessmentJ Hematol Oncol20103610.1186/1756-8722-3-6Open DOISearch in Google Scholar
Olsen JR, Robinson CG, El Naqa I, Creach KM, Drzymala RE, Bloch C, et al. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 81: 299-303. 10.1016/j.ijrobp.2011.01.038OlsenJRRobinsonCGEl NaqaICreachKMDrzymalaREBlochCet al.Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancerInt J Radiat Oncol Biol Phys20118129930310.1016/j.ijrobp.2011.01.038Open DOISearch in Google Scholar
Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non–small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 2012; 7: 1382-93. 10.1097/JTO.0b013e318260e00dGrillsISHopeAJGuckenbergerMKestinLLWerner-WasikMYanDet al.A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non–small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapyJ Thorac Oncol2012713829310.1097/JTO.0b013e318260e00dOpen DOISearch in Google Scholar
Stephans KL, Djemil T, Reddy CA, Gajdos SM, Kolar M, Mason D, et al. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. J Thorac Oncol 2009; 4: 976-82. 10.1097/JTO.0b013e3181adf509StephansKLDjemilTReddyCAGajdosSMKolarMMasonDet al.A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experienceJ Thorac Oncol200949768210.1097/JTO.0b013e3181adf509Open DOISearch in Google Scholar
